Wegovy overview
Brand name for semaglutide 2.4 mg, FDA-approved for chronic weight management and cardiovascular risk reduction in adults with overweight/obesity + established CVD.
Wegovy at a glance
Manufacturer
Novo Nordisk
FDA status
FDA-approved
Released: Last reviewed:
Brand name for semaglutide 2.4 mg, FDA-approved for chronic weight management and cardiovascular risk reduction in adults with overweight/obesity + established CVD.
Brand name for semaglutide 2.4 mg, FDA-approved for chronic weight management and cardiovascular risk reduction in adults with overweight/obesity + established CVD.